Tech Company M&A Transactions
Ischemia Technologies Acquisition
Ischemia Technologies was acquired by Inverness Medical Innovations. The acquisition was announced on 2/16/2005. Inverness Medical Innovations said the transaction price was $22.4 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/16/2005
Transaction Type
M&A
Amount
$22,400,000
M&A Terms
Under the terms of the agreement, Inverness will acquire Ischemia through a reverse triangular merger for approximately $22.4 million of Inverness common stock, subject to adjustment for certain allocated expenses and liabilities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6830 N. Broadway A
Denver, CO 80221
USA
Denver, CO 80221
USA
Phone
Website
Email Address
Not Recorded
Overview
Ischemia Technologies, Inc. is focused on developing technologies and products for revolutionizing the standard of care for patients with ischemia. The Company was founded in 1997 with the objective of commercializing the discovery of an important new biochemical marker.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Dominici
Browse more venture capital transactions:
Prev: 2/16/2005: ReproSource venture capital transaction
Next: 2/16/2005: Sandburst venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs